» Articles » PMID: 35833010

Bacteriological Profile and Antimicrobial Susceptibility Patterns of Gram-Negative Bloodstream Infection and Risk Factors Associated with Mortality and Drug Resistance: A Retrospective Study from Shanxi, China

Overview
Publisher Dove Medical Press
Date 2022 Jul 14
PMID 35833010
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: The aim of this study was to analyze the epidemiological of gram-negative bloodstream infection (GNBSI) and establish a risk prediction model for mortality and acquiring multidrug resistant (MDR), the extended spectrum beta-lactamases (ESBLs) producing and carbapenem-resistant (CR) GNBSI.

Methods: This retrospective study covered five years from January 2015 to December 2019. Data were obtained from Hospital Information System (HIS) and microbiology department records. The risk factors for mortality and acquiring MDR, ESBLs-producing and CR GNBSI were analyzed by univariable and multivariable analysis.

Results: A total of 1018 GNBSI cases were collected. A majority of GNBSI patients were in hematology ward (23.77%). There were 38.61% patients who were assigned in the 41-60 age group. was the most common gram-negative organism (49.90%). Among isolates of GNBSI, 40.47% were found to be MDR strains, 34.09% were found to be ESBLs-producing strains and 7.06% were found to be CR strains. was the most common MDR (71.36%) and ESBLs-producing strain (77.81%). was the most common CR isolate (46.15%). Multivariate analysis indicated that diabetes mellitus, solid organ tumor, non-fermentative bacteria, MDR strain, central venous cannula, urinary catheter, therapy with carbapenems or tigecycline prior 30 days of infection were independent mortality risk factors for GNBSIs. Over all, therapy with tigecycline prior 30 days of infection was the mutual predictor for mortality of GNBSI, acquiring MDR, ESBLs-producing and CR GNBSI (OR, 8.221, OR, 3.963, OR, 3.588, OR, 9.222, respectively, all < 0.001).

Conclusion: Collectively, our study implies that patients who were diagnosed as GNBSI had a younger age. Therapy with tigecycline was the mutual and paramount predictor for mortality of GNBSI, acquiring MDR, ESBLs-producing and CR GNBSI. Our investigation had provided a theoretical basis for the use of antibiotics and prevention and control of hospital infection in our region.

Citing Articles

Investigation of methicillin, beta lactam, carbapenem, and multidrug resistant bacteria from blood cultures of septicemia suspected patients in Northwest Ethiopia.

Birhanu A, Gebre G, Getaneh E, Yohannes H, Baye N, Mersha G Sci Rep. 2025; 15(1):5769.

PMID: 39962179 PMC: 11833138. DOI: 10.1038/s41598-025-86648-x.


Geographical mapping and temporal trends of Acinetobacter baumannii carbapenem resistance: A comprehensive meta-analysis.

Beig M, Parvizi E, Navidifar T, Bostanghadiri N, Mofid M, Golab N PLoS One. 2024; 19(12):e0311124.

PMID: 39680587 PMC: 11649148. DOI: 10.1371/journal.pone.0311124.


Characterization of the Pathogen Distribution and Drug Resistance in Bloodstream Infections During COVID-19 Pandemic in a Tertiary Hospital in Eastern China: Comparison with the Pre-Pandemic Period.

Gu M, Zhang X, Ni F, Wang J, Xia W, Lu Y Infect Drug Resist. 2024; 17:3689-3700.

PMID: 39221184 PMC: 11363953. DOI: 10.2147/IDR.S476267.


Antibiogram Profiling of Antibiotics in Ear, Nose, and Throat Infections in Tertiary Healthcare Settings.

Mariah Benedict Raj P, Travasso C, Muthusamy R Cureus. 2024; 16(2):e54587.

PMID: 38524079 PMC: 10959465. DOI: 10.7759/cureus.54587.


Establishment and Validation of a Risk Prediction Model for Mortality in Patients with Infection: A Retrospective Study.

Song H, Zhang H, Zhang D, Liu B, Wang P, Liu Y Infect Drug Resist. 2024; 16:7855-7866.

PMID: 38162321 PMC: 10757776. DOI: 10.2147/IDR.S423969.


References
1.
Licata F, Quirino A, Pepe D, Matera G, Bianco A, Group C . Antimicrobial Resistance in Pathogens Isolated from Blood Cultures: A Two-Year Multicenter Hospital Surveillance Study in Italy. Antibiotics (Basel). 2020; 10(1). PMC: 7824585. DOI: 10.3390/antibiotics10010010. View

2.
Bell T, OGrady N . Prevention of Central Line-Associated Bloodstream Infections. Infect Dis Clin North Am. 2017; 31(3):551-559. PMC: 5666696. DOI: 10.1016/j.idc.2017.05.007. View

3.
Fortun J, Sanz M, Madero L, Lopez J, de la Torre J, Jarque I . Update on bacteraemia in oncology and hematology. Enferm Infecc Microbiol Clin. 2011; 29 Suppl 4:48-53. DOI: 10.1016/S0213-005X(11)70036-2. View

4.
Timsit J, Ruppe E, Barbier F, Tabah A, Bassetti M . Bloodstream infections in critically ill patients: an expert statement. Intensive Care Med. 2020; 46(2):266-284. PMC: 7223992. DOI: 10.1007/s00134-020-05950-6. View

5.
Halaji M, Shahidi S, Ataei B, Atapour A, Feizi A, Havaei S . Molecular epidemiology of bla gene-producing uropathogenic Escherichia coli among Iranian kidney transplant patients: clonal dissemination of CC131 and CC10. Ann Clin Microbiol Antimicrob. 2021; 20(1):65. PMC: 8424993. DOI: 10.1186/s12941-021-00470-7. View